← All companies

GNMS

Genmab A/S

GNMSF Nasdaq Pharmaceutical Preparations EDGAR ↗

$282.00

-7.16 -2.48%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$216.31 – $352.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 15, 2026 6-K Jun 29, 2026 6-K Jun 17, 2026 6-K Jun 16, 2026 6-K Jun 15, 2026 6-K Jun 15, 2026 6-K Jun 11, 2026 6-K May 29, 2026 6-K May 13, 2026 6-K May 12, 2026 6-K May 8, 2026 6-K May 7, 2026 6-K Apr 17, 2026 6-K Apr 17, 2026 6-K Apr 14, 2026 6-K Apr 14, 2026 6-K Apr 1, 2026 6-K Apr 1, 2026 6-K Mar 30, 2026 6-K Mar 23, 2026 6-K Mar 19, 2026 6-K Mar 19, 2026 6-K Mar 16, 2026 6-K Mar 9, 2026 6-K Mar 4, 2026 6-K Mar 3, 2026 6-K Mar 2, 2026 6-K Feb 27, 2026 6-K Feb 25, 2026 6-K Feb 24, 2026 6-K Feb 23, 2026 6-K Feb 20, 2026 6-K Feb 18, 2026 6-K Feb 17, 2026 20-F Feb 17, 2026 6-K Feb 3, 2026 6-K Jan 29, 2026 6-K Jan 21, 2026 6-K Jan 16, 2026 6-K Dec 29, 2025